Found: 93
Select item for more details and to access through your institution.
Alzheimer disease–related biomarkers and cancer-related cognitive decline: the Thinking and Living with Cancer study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1495, doi. 10.1093/jnci/djae113
- By:
- Publication type:
- Article
Correction: Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217.
- Published in:
- Alzheimer's Research & Therapy, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13195-022-01005-8
- By:
- Publication type:
- Article
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00939-9
- By:
- Publication type:
- Article
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231.
- Published in:
- Alzheimer's Research & Therapy, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13195-021-00939-9
- By:
- Publication type:
- Article
A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1-42 peptide in human plasma with utility for studies of Alzheimer's disease therapeutics.
- Published in:
- Alzheimer's Research & Therapy, 2016, v. 8, p. 1, doi. 10.1186/s13195-016-0225-7
- By:
- Publication type:
- Article
Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels.
- Published in:
- Molecular Neurodegeneration, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13024-022-00578-0
- By:
- Publication type:
- Article
Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Head‐to‐Head Comparison of Tau and Amyloid Positron Emission Tomography Visual Reads for Differential Diagnosis of Neurodegenerative Disorders: An International, Multicenter Study.
- Published in:
- Annals of Neurology, 2024, v. 96, n. 3, p. 476, doi. 10.1002/ana.27008
- By:
- Publication type:
- Article
Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels.
- Published in:
- Acta Neuropathologica Communications, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40478-021-01307-2
- By:
- Publication type:
- Article
Blood‐based biomarkers for Alzheimer's disease.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.15252/emmm.202114408
- By:
- Publication type:
- Article
Tau PET correlates with different Alzheimer's disease‐related features compared to CSF and plasma p‐tau biomarkers.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 8, p. 1, doi. 10.15252/emmm.202114398
- By:
- Publication type:
- Article
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 6, p. 1, doi. 10.15252/emmm.202114022
- By:
- Publication type:
- Article
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 12, p. N.PAG, doi. 10.15252/emmm.201911170
- By:
- Publication type:
- Article
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Plasma‐derived biomarkers of Alzheimer's disease and neuropsychiatric symptoms: A community‐based study.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023, v. 15, n. 3, p. 1, doi. 10.1002/dad2.12461
- By:
- Publication type:
- Article
Comparative diagnostic performance of plasma P‐tau217 and P‐tau181 in Alzheimer's disease and frontotemporal lobar degeneration and correlations with [18F]Flortaucipir‐PET uptake: Biomarkers (non‐neuroimaging)/Plasma/Serum/Urine biomarkers
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045755
- By:
- Publication type:
- Article
Plasma phospho‐tau217 is a potential early diagnostic and prognostic biomarker of Alzheimer's disease: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042489
- By:
- Publication type:
- Article
Plasma phospho‐tau217 can detect Alzheimer‐like pathology in Parkinson's disease with dementia and dementia with Lewy bodies: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042468
- By:
- Publication type:
- Article
Comparison of cerebrospinal fluid phosphorylated tau 181 and 217 for cognitive progression: Biomarkers (non‐neuroimaging): Longitudinal and prognostic biomarker studies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040503
- By:
- Publication type:
- Article
P4‐540: CSF PTAU‐217 PERFORMS BETTER THAN PTAU‐181 IN DETECTING ABNORMAL RETENTION OF <sup>18</sup>F‐FLORTAUCIPIR AND DISCRIMINATING ALZHEIMER'S DISEASE FROM OTHER NEURODEGENERATIVE DISORDERS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1523, doi. 10.1016/j.jalz.2019.08.087
- By:
- Publication type:
- Article
P2‐231: EXPLORING THE NEED FOR ROBUST BIOMARKER ASSAYS IN ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P668, doi. 10.1016/j.jalz.2019.06.2638
- By:
- Publication type:
- Article
O2‐05‐04: PLASMA PTAU181 LEVELS REFLECT [18F]AV1451 TAU PET UPTAKE ACROSS THE TAUOPATHY SPECTRUM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P547, doi. 10.1016/j.jalz.2019.06.4478
- By:
- Publication type:
- Article
P1‐048: PLASMA NF‐L AS A BIOMARKER FOR NEURODEGENERATION IN MILD AD SUBJECTS IN THE PHASE 2 NAVIGATE‐AD STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P251, doi. 10.1016/j.jalz.2019.06.073
- By:
- Publication type:
- Article
Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, n. 8, p. 989, doi. 10.1016/j.jalz.2018.02.013
- By:
- Publication type:
- Article
P1‐326: THE USE OF THE DIGITAL CLOCK DRAWING TEST (DCTCLOCK™) IN THE SCREENING PHASE OF CLINICAL TRIALS FOR ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P416, doi. 10.1016/j.jalz.2018.06.333
- By:
- Publication type:
- Article
PLASMA TOTAL TAU, COGNITIVE DECLINE, AND RISK OF MILD COGNITIVE IMPAIRMENT IN THE MAYO CLINIC STUDY ON AGING.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1032, doi. 10.1016/j.jalz.2017.06.1455
- By:
- Publication type:
- Article
Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, n. 12, p. 1226, doi. 10.1016/j.jalz.2016.06.001
- By:
- Publication type:
- Article
EXPLORING AV1451 BINDING THROUGH BIOCHEMICAL AND BIOPHYSICAL ANALYSIS OF PHF TAU FROM HUMAN AND TG4510 BRAINS WITH ELECTRON MICROSCOPY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P844, doi. 10.1016/j.jalz.2016.06.1729
- By:
- Publication type:
- Article
EXPLORING THE UTILITY OF CSF NEUROGRANIN LEVELS IN AN ALZHEIMER’S DISEASE CLINICAL TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1062, doi. 10.1016/j.jalz.2016.06.2218
- By:
- Publication type:
- Article
LEVELS OF TAU PROTEIN IN PLASMA ARE ASSOCIATED WITH NEURODEGENERATION AND COGNITIVE FUNCTION IN A POPULATION-BASED ELDERLY COHORT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P877, doi. 10.1016/j.jalz.2016.06.1812
- By:
- Publication type:
- Article
Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 5, p. 756, doi. 10.1002/acn3.51529
- By:
- Publication type:
- Article
Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populations.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23746-0
- By:
- Publication type:
- Article
Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment.
- Published in:
- Alzheimer's Research & Therapy, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13195-023-01302-w
- By:
- Publication type:
- Article
Site localization of sialyl Lewisx antigen on α1‐acid glycoprotein by high performance liquid chromatography–electrospray mass spectrometry.
- Published in:
- Glycobiology, 1998, v. 8, n. 8, p. 755, doi. 10.1093/glycob/8.8.755
- By:
- Publication type:
- Article
Plasma biomarkers predict amyloid pathology in cognitively normal monozygotic twins after 10 years.
- Published in:
- Brain Communications, 2023, v. 5, n. 1, p. 1, doi. 10.1093/braincomms/fcad024
- By:
- Publication type:
- Article
Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2022, v. 79, n. 12, p. 1250, doi. 10.1001/jamaneurol.2022.3392
- By:
- Publication type:
- Article
Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 9, p. 1108, doi. 10.1001/jamaneurol.2021.2293
- By:
- Publication type:
- Article
Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease.
- Published in:
- JAMA Neurology, 2021, v. 78, n. 2, p. 149, doi. 10.1001/jamaneurol.2020.4201
- By:
- Publication type:
- Article
Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model.
- Published in:
- Molecular Neurodegeneration, 2018, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13024-018-0296-y
- By:
- Publication type:
- Article
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15436-0
- By:
- Publication type:
- Article
Plasma Phospho‐Tau Identifies Alzheimer's Co‐Pathology in Patients with Lewy Body Disease.
- Published in:
- Movement Disorders, 2021, v. 36, n. 3, p. 767, doi. 10.1002/mds.28370
- By:
- Publication type:
- Article
Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 9, p. 1907, doi. 10.3390/jcm10091907
- By:
- Publication type:
- Article
Evaluation of Plasma Biomarkers for A/T/N Classification of Alzheimer Disease Among Adults of Caribbean Hispanic Ethnicity.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e238214, doi. 10.1001/jamanetworkopen.2023.8214
- By:
- Publication type:
- Article
Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging.
- Published in:
- JAMA Neurology, 2017, v. 74, n. 9, p. 1073, doi. 10.1001/jamaneurol.2017.1359
- By:
- Publication type:
- Article
Pharmacological characterisation of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons.
- Published in:
- Psychopharmacology, 2014, v. 231, n. 6, p. 1105, doi. 10.1007/s00213-013-3384-2
- By:
- Publication type:
- Article
Transcriptomic Analysis of Induced Pluripotent Stem Cells Derived from Patients with Bipolar Disorder from an Old Order Amish Pedigree.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0142693
- By:
- Publication type:
- Article
Pharmacological Characterisation of Nicotinic Acetylcholine Receptors Expressed in Human iPSC-Derived Neurons.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0125116
- By:
- Publication type:
- Article
Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health‐related comorbidities in a community‐dwelling cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 6, p. 4159, doi. 10.1002/alz.13835
- By:
- Publication type:
- Article